This page contains a Flash digital edition of a book.
24 food hygiEnE & safEty

CCPs. They are as follows: be to keep lids closed on kettles. Elimination of the
1. It is a process step. issue may involve a redesign of the area to eliminate the
2. It must eliminate or reduce to an acceptable level a formation of the condensation.
food safety issue.
3. The process will produce a viable product even if the
Summary
process step fails. There are several tools available for identifying CCPs
and/or in a process. The desired result of each method is
4. The process step is there for no other reason than the identification of elimination steps for food safety
food safety. hazards. It is important to remember that the results may
The Process Hazard Analysis approach presented by differ between similar process and facilities, regardless
AIB follows the general concept of root cause analysis. of the method used. Not because of the technique used,
Once an issue is identified, the key to success becomes rather because of the possible differences in ingredients,
the resolution of the issue. Resolution can come in suppliers and process conditions. p
the form of control or elimination. For example,
condensation may develop in a particular area of the Enter 24 or ✔ at www.scientistlive.com/efood
plant. To control the issue, you may increase frequency
of cleaning to ensure that no biological issues arise from Kerry Beach is with AIB International Inc, Manhattan, Kansas
the presence of condensation. Another control would USA. www.aibonline.org
isoflavonE patEnt uphEld
t
he European patent office (Epo) has having access to this important positioning of scientific work. soylife has been part of
concluded to uphold the validity of for their products.” more than 35 proprietary studies in the
the main application patent for the use the patent was upheld by the Epo in fields of menopause, bone health, heart
of isoflavones in consumer products. this a hearing in Munich, germany, on July 9th. health, and cognitive function. Results
patent is part of a series of intellectual the conclusion came after more than five of one recent study, the osteoporosis
properties (ips) related to isoflavones that years of opposition and defense after the prevention using soy (opus) study, show
covers the use of isoflavones for major Epo originally granted the patent in 2004. that soy germ isoflavones from soylife are
health indications. this patent is based upon an international safe and effective to improve bone health
health ingredients manufacturer patent filing by novogen Research in 1992 in a group of 400 post-menopausal women.
frutarom, with headquarters in this is in addition to previous
israel, is the sole licensee for this studies showing improvements
patent for isoflavones sourced in menopausal symptoms with
from soy germ, with its soylife soylife.
products. frutarom congratulates soylife is available in
the patent holder novogen concentrations varying from
Research with the conclusion of 3 per cent to 40 per cent and
the Epo, upholding the validity of can be used in tablets, capsules,
this patent. soft-gel capsules and multiple
the patent Ep 0656786 functional food applications.
covers the use of the isoflavones “We intend to work in
genistein, daidzein and their cooperation with potential
natural derivatives for health customers to ensure that they
indications such as menopausal can use the positioning covered
symptoms and pre-menstrual by the patent,” continues hart.
syndrome (pMs). Consumer “this is a validation of our
products containing from 20 to strategy of investing in and
200 mg (daily dosage) of isoflavones that for its work with isoflavone extracts. the developing intellectual property, including
are marketed for these health indications European patent was applied for in 1993, patents and scientific studies, to support
may fall under the protection of this patent. and it was granted by the Epo in 2004. a soylife and the isoflavone market. We
“Women’s health, and specifically the group of commercial interests in Europe are convinced that the combination of
treatment of menopausal symptoms, is registered opposition to the patent, and scientific backing and patent protection
the most common indication for products since then it has been the subject of an make soylife the best choice for
containing isoflavones,” says david hart, intense battle. manufacturers.”. p
product Manager soylife at frutarom. “in frutarom’s soylife is the leading soy
addition to the strong science backing up germ isoflavone product on the market. for more information, visit
soylife, our customers will benefit from isoflavones are supported by a large body www.frutarom.com
www.scientistlive.com
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44
Produced with Yudu - www.yudu.com